Cell Culture Market to Reach $35.5 Billion by 2035

Cell Culture market was valued at $16.3 billion in 2025 and is expected to reach $35.5 billion by 2035, registering a CAGR of 8.1% during the forecast period from 2026 to 2035. The growth of the global cell culture market is strongly driven by the rising demand for biologics and vaccine production, where cell culture systems form the backbone of manufacturing processes. Biopharmaceutical companies are increasingly shifting toward complex biologics such as monoclonal antibodies, cell and gene therapies, and recombinant proteins, all of which rely heavily on advanced cell culture techniques. This shift is directly increasing the need for high-performance media, bioreactors, and single-use systems to ensure scalability and regulatory compliance. In addition, global preparedness for infectious diseases continues to reinforce investments in vaccine manufacturing infrastructure, further strengthening the adoption of cell culture technologies. As a result, the market is experiencing sustained expansion aligned with the growing biologics pipeline and production capacity enhancements.

Browse the full report description of “Cell Culture Market Size, Share & Trends Analysis Report by Application (Biopharmaceutical and Therapeutic Applications, Cancer Research, Stem Cell Technologies, Drug Screening and Development, Tissue Engineering and Regenerative Medicine, and Others), by Products (Equipment, Cell Culture Vessels, Consumables, and Others), and by End Users (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/cell-culture-market

Supporting this trend, data from verified sources highlight the rapid expansion of biologics and vaccine-related activities. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA, 2024), biologics now account for over one-third of the global pharmaceutical pipeline, reflecting a structural shift toward cell-based production systems. The World Health Organization (WHO, 2024) reported continued global investments in vaccine manufacturing capacity following pandemic preparedness initiatives, with multiple countries expanding local production facilities. Additionally, the U.S. Food and Drug Administration (FDA, 2025) noted that biologics license applications continue to represent a growing share of new drug approvals, indicating sustained reliance on cell culture processes. These developments collectively validate the increasing dependence on cell culture technologies across therapeutic and preventive healthcare segments.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Application
  • Products
  • End Users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – Becton, Dickinson and Company, Corning Inc, Danaher Corp., Merck KGaA (MilliporeSigma), Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cell Culture Market Report Segment

By Application

• Biopharmaceutical and Therapeutic Applications
• Cancer Research
• Stem Cell Technologies
• Drug Screening and Development
• Tissue Engineering and Regenerative Medicine
• Others

By Products

• Equipment
• Cell Culture Vessels
• Consumables
• Others

By End Users

• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Others

Global Cell Culture Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-culture-market